Cargando…
Conserved crosstalk between histone deacetylation and H3K79 methylation generates DOT1L‐dose dependency in HDAC1‐deficient thymic lymphoma
DOT1L methylates histone H3K79 and is aberrantly regulated in MLL‐rearranged leukemia. Inhibitors have been developed to target DOT1L activity in leukemia, but cellular mechanisms that regulate DOT1L are still poorly understood. We have identified the histone deacetylase Rpd3 as a negative regulator...
Autores principales: | Vlaming, Hanneke, McLean, Chelsea M, Korthout, Tessy, Alemdehy, Mir Farshid, Hendriks, Sjoerd, Lancini, Cesare, Palit, Sander, Klarenbeek, Sjoerd, Kwesi‐Maliepaard, Eliza Mari, Molenaar, Thom M, Hoekman, Liesbeth, Schmidlin, Thierry T, Altelaar, AF Maarten, van Welsem, Tibor, Dannenberg, Jan‐Hermen, Jacobs, Heinz, van Leeuwen, Fred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627229/ https://www.ncbi.nlm.nih.gov/pubmed/31304633 http://dx.doi.org/10.15252/embj.2019101564 |
Ejemplares similares
-
Direct screening for chromatin status on DNA barcodes in yeast delineates the regulome of H3K79 methylation by Dot1
por: Vlaming, Hanneke, et al.
Publicado: (2016) -
The histone methyltransferase DOT1L prevents antigen-independent differentiation and safeguards epigenetic identity of CD8(+) T cells
por: Kwesi-Maliepaard, Eliza Mari, et al.
Publicado: (2020) -
DOT1L inhibition does not modify the sensitivity of cutaneous T cell lymphoma to pan-HDAC inhibitors in vitro
por: Kwesi-Maliepaard, Eliza Mari, et al.
Publicado: (2022) -
Histone methyltransferase DOT1L controls state‐specific identity during B cell differentiation
por: Aslam, Muhammad Assad, et al.
Publicado: (2021) -
Dot1 promotes H2B ubiquitination by a methyltransferase-independent mechanism
por: van Welsem, Tibor, et al.
Publicado: (2018)